Risk factors for lung disease progression in children with cystic fibrosis

Hafez Al Momani,Audrey Perry,Rhys Jones,Melissa McDonnell,Amaran Krishnan,Andrew Robertson,Mike Griffin,Robert Rutherford,Malcolm Brodlie,Jeff Pearson,Steve Bourke,Chris Ward

EUROPEAN RESPIRATORY JOURNAL（2018）

引用 1|浏览4

暂无评分

摘要

We call for studies of widespread use of proton pump inhibitor therapy in people with cystic fibrosis and chronic lung disease; these should evaluate patient benefit and potential iatrogenic effects, including dysregulation of aerodigestive homeostasis http://ow.ly/ym6H30lxxZu

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要